A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials

Glioblastoma (GBM) is the most common and fatal primary central nervous system malignancy in adults with a median survival of less than 15 months. Surgery, radiation, and chemotherapy are the standard of care and provide modest benefits in survival, but tumor recurrence is inevitable. The poor progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Siddhartha, Jackson, Christina, Kim, Timothy, Choi, John, Lim, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521200/
https://www.ncbi.nlm.nih.gov/pubmed/30991681
http://dx.doi.org/10.3390/cancers11040537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521200/
https://www.ncbi.nlm.nih.gov/pubmed/30991681
http://dx.doi.org/10.3390/cancers11040537

Ejemplares similares